BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29846113)

  • 1. Mechanistic target of rapamycin: integrating growth factor and nutrient signaling in the collecting duct.
    Brown AL; Fluitt MB; Ecelbarger CM
    Am J Physiol Renal Physiol; 2018 Sep; 315(3):F413-F416. PubMed ID: 29846113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium Activates mTORC2-dependent SGK1 Phosphorylation to Stimulate Epithelial Sodium Channel: Role in Rapid Renal Responses to Dietary Potassium.
    Saha B; Shabbir W; Takagi E; Duan XP; Leite Dellova DCA; Demko J; Manis A; Loffing-Cueni D; Loffing J; Sørensen MV; Wang WH; Pearce D
    J Am Soc Nephrol; 2023 Jun; 34(6):1019-1038. PubMed ID: 36890646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTORC2 critically regulates renal potassium handling.
    Grahammer F; Nesterov V; Ahmed A; Steinhardt F; Sandner L; Arnold F; Cordts T; Negrea S; Bertog M; Ruegg MA; Hall MN; Walz G; Korbmacher C; Artunc F; Huber TB
    J Clin Invest; 2016 May; 126(5):1773-82. PubMed ID: 27043284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTOR signaling in renal ion transport.
    Adella A; de Baaij JHF
    Acta Physiol (Oxf); 2023 May; 238(1):e13960. PubMed ID: 36906912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potassium acts through mTOR to regulate its own secretion.
    Sørensen MV; Saha B; Jensen IS; Wu P; Ayasse N; Gleason CE; Svendsen SL; Wang WH; Pearce D
    JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31013253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling.
    Yoon MS
    Nutrients; 2017 Oct; 9(11):. PubMed ID: 29077002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the epithelial Na+ channel by the mTORC2/SGK1 pathway.
    Lang F; Pearce D
    Nephrol Dial Transplant; 2016 Feb; 31(2):200-5. PubMed ID: 26163195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of mTORC1 in collecting ducts causes hyperkalemia.
    Chen Z; Dong H; Jia C; Song Q; Chen J; Zhang Y; Lai P; Fan X; Zhou X; Liu M; Lin J; Yang C; Li M; Gao T; Bai X
    J Am Soc Nephrol; 2014 Mar; 25(3):534-45. PubMed ID: 24203997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship.
    Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH
    Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutrient regulation of the mTOR complex 1 signaling pathway.
    Kim SG; Buel GR; Blenis J
    Mol Cells; 2013 Jun; 35(6):463-73. PubMed ID: 23694989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects.
    Jhanwar-Uniyal M; Amin AG; Cooper JB; Das K; Schmidt MH; Murali R
    Adv Biol Regul; 2017 May; 64():39-48. PubMed ID: 28189457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian target of rapamycin and the kidney. I. The signaling pathway.
    Lieberthal W; Levine JS
    Am J Physiol Renal Physiol; 2012 Jul; 303(1):F1-10. PubMed ID: 22419691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrete Mechanistic Target of Rapamycin Signaling Pathways, Stem Cells, and Therapeutic Targets.
    Jhanwar-Uniyal M; Zeller SL; Spirollari E; Das M; Hanft SJ; Gandhi CD
    Cells; 2024 Feb; 13(5):. PubMed ID: 38474373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutrient signaling to mTOR and cell growth.
    Jewell JL; Guan KL
    Trends Biochem Sci; 2013 May; 38(5):233-42. PubMed ID: 23465396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
    Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
    Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic modeling of signal transduction by mTOR complexes in cancer.
    Dorvash M; Farahmandnia M; Mosaddeghi P; Farahmandnejad M; Saber H; Khorraminejad-Shirazi M; Azadi A; Tavassoly I
    J Theor Biol; 2019 Dec; 483():109992. PubMed ID: 31493485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrolyte transport in the renal collecting duct and its regulation by the renin-angiotensin-aldosterone system.
    Yamazaki O; Ishizawa K; Hirohama D; Fujita T; Shibata S
    Clin Sci (Lond); 2019 Jan; 133(1):75-82. PubMed ID: 30622159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin inhibition of mTORC1 reverses lithium-induced proliferation of renal collecting duct cells.
    Gao Y; Romero-Aleshire MJ; Cai Q; Price TJ; Brooks HL
    Am J Physiol Renal Physiol; 2013 Oct; 305(8):F1201-8. PubMed ID: 23884148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation.
    Ding X; Bloch W; Iden S; Rüegg MA; Hall MN; Leptin M; Partridge L; Eming SA
    Nat Commun; 2016 Oct; 7():13226. PubMed ID: 27807348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of B lymphocyte development and functions by the mTOR signaling pathways.
    Iwata TN; Ramírez-Komo JA; Park H; Iritani BM
    Cytokine Growth Factor Rev; 2017 Jun; 35():47-62. PubMed ID: 28583723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.